Dexamethasone

Generic Name
Dexamethasone
Brand Names
Baycadron, Ciprodex, Decadron, Dexamethasone Intensol, Dextenza, Dioptrol, Hexadrol, Hidex 6-day Taper, Maxidex, Maxitrol, Neofordex, Ozurdex, Taperdex 12 Day Taper, Taperdex 6 Day Taper, Taperdex 7-day Taper, Tobradex, Zcort 7 Day Taper
Drug Type
Small Molecule
Chemical Formula
C22H29FO5
CAS Number
50-02-2
Unique Ingredient Identifier
7S5I7G3JQL
Background

Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions. Developed in 1957, it is structurally similar to other corticosteroids like hydrocortisone and prednisolone.
...

Indication

Dexamethasone and ciprofloxacin otic suspension is indicated for bacterial infections with inflammation in acute otitis media and acute otitis externa. Intramuscular and intravenous injections are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, an...

Associated Conditions
Acute Gouty Arthritis, Acute Leukemia, Acute Otitis Externa, Acute Otitis Media (AOM), Adrenocortical Hyperfunction, Adrenocortical Insufficiency, Allergic Conjunctivitis (AC), Alopecia Areata (AA), Ankylosing Spondylitis (AS), Aspiration Pneumonitis, Asthma, Atopic Dermatitis, Berylliosis, Bullous dermatitis herpetiformis, Bursitis, Chorioretinitis, Choroiditis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Conjunctivitis, Contact Dermatitis, Cushing's Syndrome, Dermatitis, Diabetic Macular Edema (DME), Discoid Lupus Erythematosus (DLE), Drug hypersensitivity reaction, Edema of the cerebrum, Epicondylitis, Episcleritis, Erythroblastopenia, Eye Infections, Eye allergy, Glaucoma, Hypercalcemia, Immune Thrombocytopenia (ITP), Infection, Inflammation, Inflammation of the External Auditory Canal, Intraocular Inflammation, Iridocyclitis, Iritis, Keloids Scars, Keratitis, Lichen Planus (LP), Lichen simplex chronicus, Loeffler's syndrome, Lymphoma, Macular Edema, Meningitis caused by Mycobacterium Tuberculosis, Middle ear inflammation, Mucosal Inflammation of the eye, Multiple Myeloma (MM), Muscle Inflammation caused by Cataract Surgery of the eye, Mycosis Fungoides (MF), Necrobiosis lipoidica diabeticorum, Non-infectious Posterior Uveitis, Ocular Infections, Irritations and Inflammations, Ocular Inflammation, Ocular Inflammation and Pain, Ocular Irritation, Ocular Itching, Ophthalmia, Sympathetic, Optic Neuritis, Otitis Externa, Pemphigus, Perennial Allergic Rhinitis (PAR), Phlyctenular keratoconjunctivitis, Postoperative Infections of the eyes caused by susceptible bacteria, Posttraumatic Osteoarthritis, Regional Enteritis, Rheumatoid Arthritis, Rheumatoid Arthritis, Juvenile, Rosacea, Sarcoidosis, Scleritis, Seasonal Allergic Rhinitis, Secondary thrombocytopenia, Serum Sickness, Severe Seborrheic Dermatitis, Stevens-Johnson Syndrome, Synovitis, Systemic Lupus Erythematosus, Tenosynovitis, Trichinosis, Tuberculosis (TB), Ulcerative Colitis, Uveitis, Vernal Keratoconjunctivitis, Acquired immune hemolytic anemia, Acute rheumatic carditis, Anterior eye segment inflammation, Corticosteroid-responsive dermatoses, Ear infection-not otherwise specified caused by susceptible bacteria, Exfoliative erythroderma, Granuloma annulare lesions, Non-suppurative Thyroiditis, Ocular bacterial infections, Severe Psoriasis, Steroid-responsive inflammation of the eye, Swelling of the eyes, Varicella-zoster virus acute retinal necrosis, Watery itchy eyes
Associated Therapies
-
Clinical Trials
Related News

Rapid DFLC Response Predict CHR in AL Amyloidosis

First Posted Date
2024-10-04
Last Posted Date
2024-10-30
Lead Sponsor
Peking University People's Hospital
Target Recruit Count
50
Registration Number
NCT06627309
Locations
🇨🇳

Fuxing Hospital affiliated to Capital Medical University, Beijing, Beijing, China

🇨🇳

Peking University People's Hospital, Beijing, Beijing, China

Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease

First Posted Date
2024-10-04
Last Posted Date
2024-12-04
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
28
Registration Number
NCT06627751

Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia

First Posted Date
2024-10-03
Last Posted Date
2024-10-03
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
52
Registration Number
NCT06624436
Locations
🇳🇱

Intensive Care Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands

SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

First Posted Date
2024-10-01
Last Posted Date
2024-12-04
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
15
Registration Number
NCT06622005

Dexamethasone for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery

First Posted Date
2024-09-27
Last Posted Date
2024-09-27
Lead Sponsor
Poznan University of Medical Sciences
Target Recruit Count
60
Registration Number
NCT06616220
Locations
🇵🇱

Department of Spine Diseases and Pediatric Orthopedics, University of Medical Sciences, Poznań, Poland, Poznań, Wielkopolska, Poland

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

First Posted Date
2024-09-27
Last Posted Date
2024-09-27
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
378
Registration Number
NCT06616584

Phase II Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer

First Posted Date
2024-09-27
Last Posted Date
2024-12-11
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
58
Registration Number
NCT06616597
Locations
🇺🇸

Sibley Memorial Hospital, Washington, District of Columbia, United States

🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-refractory Multiple Myeloma (QUINTESSENTIAL-2)

First Posted Date
2024-09-26
Last Posted Date
2024-12-20
Lead Sponsor
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Target Recruit Count
440
Registration Number
NCT06615479
Locations
🇦🇺

Local Institution - 0190, Liverpool, New South Wales, Australia

🇦🇺

Local Institution - 0191, Melbourne, Victoria, Australia

🇺🇸

Local Institution - 0071, Birmingham, Alabama, United States

and more 108 locations

Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency Department

First Posted Date
2024-09-19
Last Posted Date
2024-09-19
Lead Sponsor
WellSpan Health
Target Recruit Count
192
Registration Number
NCT06603662
Locations
🇺🇸

WellSpan York Hospital, York, Pennsylvania, United States

Safety and Efficacy of a Drug Eluting Slim Modiolar Electrode Array

Not Applicable
Recruiting
Conditions
Hearing Loss
Interventions
Device: Cochlear implant
Drug: Dexamethasone
First Posted Date
2024-09-19
Last Posted Date
2024-11-26
Lead Sponsor
Cochlear
Target Recruit Count
56
Registration Number
NCT06598059
Locations
🇺🇸

Washington Univeristy, St. Louis, Missouri, United States

🇺🇸

Rocky Mountain Ear Center, Englewood, Colorado, United States

🇺🇸

University of Iowa, Iowa City, Iowa, United States

and more 1 locations
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy